Scleroderma, Systemic Clinical Trial
Official title:
Phenotyping of Chronic Pain in Diffused Systemic Scleroderma: Characteristics and Perturbations of Mechanisms of Pain, Impact on the Quality of Life and Correlations of Fatigue, Sleeping Disorders and Mood or Anxiety Disorders
The primary objective of the study is to describe the different phenotyping of pain in systemic scleroderma patients and perturbations of mechanisms of the pain. As secondary objectives, the study aims to describe the importances of overall symptoms in alteration of quality of life and conserve the questions which will be associated in a unique questionnaire in order to evaluate the pain, the fatigue and the sleeping disorders in diffused systemic scleroderma patients.
This is a prospective, non-randomized, controlled study. Beside the routine care, the patients will have only one visit in the study during which the informed consent will be signed, also the following will be performed: pain evaluation, blood sampling, questionnaires and Sudoscan, test QST. 100 patients will be enrolled in total with 50 in each group (scleroderma with pain vs. scleroderma without pain, 1:1 ratio), the duration of inclusion is estimated for 23 months. 2 centers will be involved in the enrollment of patients: rheumatology department and interne medicine department of Cochin hospital-APHP. One center will perform the evaluations of pain for all patients: center of pain of Cochin hospital - APHP. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03965780 -
The SPIN - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)
|
N/A | |
Terminated |
NCT02558543 -
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
|
Phase 2 | |
Withdrawn |
NCT01202045 -
Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
|
N/A | |
Terminated |
NCT01445821 -
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
|
Phase 3 | |
Recruiting |
NCT05878717 -
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
|
Phase 3 | |
Recruiting |
NCT03559465 -
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
|
N/A | |
Not yet recruiting |
NCT03610217 -
Pragmatic Clinical Trials in Scleroderma
|
N/A | |
Completed |
NCT02655640 -
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis
|
N/A | |
Recruiting |
NCT04804930 -
Trichoscopy and Systemic Scleroderma
|
||
Completed |
NCT03675581 -
A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
|
Phase 1 | |
Completed |
NCT03221257 -
Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate
|
Phase 2 | |
Recruiting |
NCT05559580 -
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
|
Phase 2 | |
Completed |
NCT00442611 -
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
|
Phase 1/Phase 2 | |
Completed |
NCT00001330 -
Study of Silicone-Associated Connective Tissue Diseases
|
N/A | |
Completed |
NCT02597933 -
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
|
Phase 3 | |
Not yet recruiting |
NCT05821335 -
Leap Motion Based Gamefication Exercises in the Individuals With Systemic Sclerosis
|
N/A | |
Completed |
NCT00333437 -
Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
|
N/A | |
Completed |
NCT00025818 -
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
|
Phase 3 | |
Not yet recruiting |
NCT05351060 -
Novel Splinting Technique Using 3D Models
|
N/A | |
Not yet recruiting |
NCT04563481 -
Effectiveness of Telerehabilitation on Scleroderma
|
N/A |